Supreme Court Questions Centre on Medicine Pricing and NPPA's Role
The Supreme Court questioned the Centre over the significant gap between the maximum retail price (MRP) of medicines and the prices retailers pay, raising concerns about government oversight and the role of the National Pharmaceutical Pricing Authority (NPPA), which the court described as 'totally defunct.' The Centre defended its policy of not controlling the entire pharmaceutical ecosystem and noted that medicine prices in India are among the lowest globally. The court reserved its order after hearing petitions on medicine pricing and trade margin caps on anti-cancer drugs.
First-hand measurement across 8 sources
We measured how 8 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is negative (29/100). Lens Score 63/100.
Outlets measured: moneycontrol, httpswwwoutlookindiacom, thetelegraph, english, hindustantimes, thetribune, hindustantimes, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (28–32/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 27 Oct, 10:15 am. Other outlets followed.